A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up.
Few studies have evaluated long-term health-related quality of life (HRQL) in patients during auto-SCT. This prospective study examined HRQL in 96 eligible patients before, during and up to 3 years after auto-SCT. The aim of the study was to make a comprehensive assessment of the frequency and severity of different symptoms in patients undergoing auto-SCT. The European Organization for Treatment and Research of Cancer Quality of Life Questionnaire (EORTC QLQ C-30) was administered 13 times. The second week during treatment was the period when patients had the lowest HRQL regarding both total quality of life and function and symptom scales. The patients recovered quickly and just two months after transplantation the baseline values were restored. Three years after transplantation most of the items in the questionnaire had stabilized, except role function and dyspnea, which had improved. There were significant differences between multiple myeloma (MM) and lymphoma patients' physical function, quality of life, fatigue and pain during week 2. At the 3-year follow-up, lymphoma patients indicated a better HRQL than MM patients. The quick recovery of patients after transplantation suggests that treatment is well tolerated; however, the supportive care could be improved at week 2, especially for the lymphoma patients.
Department of Hematology, Linköping University Hospital, Linköping, Sweden. ulla.frodin@lio.se
U
U
Frödin
S
S
Börjeson
J
J
Lyth
K
K
Lotfi
D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008223:Lymphoma / Q000188:drug therapy / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000601:surgery; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000601:surgery; D011446:Prospective Studies; D011788:Quality of Life; D012509:Sarcoma / Q000188:drug therapy / Q000601:surgery; D033581:Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D011795:Surveys and Questionnaires; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000601:surgery